Your browser doesn't support javascript.
loading
Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors.
Yang, Yaewon; Lim, Okjae; Kim, Tae Min; Ahn, Yong-Oon; Choi, Hana; Chung, Hyejin; Min, Bokyung; Her, Jung Hyun; Cho, Sung Yoo; Keam, Bhumsuk; Lee, Se-Hoon; Kim, Dong-Wan; Hwang, Yu Kyeong; Heo, Dae Seog.
Afiliação
  • Yang Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lim O; Cell Therapy Team, MOGAM Biotechnology Institute, Yongin, Gyeonggi-do, Korea.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. gabriel9@snu.ac.kr ykhwang@mogam.re.kr.
  • Ahn YO; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Choi H; Cell Therapy Team, MOGAM Biotechnology Institute, Yongin, Gyeonggi-do, Korea.
  • Chung H; Cell Therapy Team, MOGAM Biotechnology Institute, Yongin, Gyeonggi-do, Korea.
  • Min B; Cell Therapy Team, MOGAM Biotechnology Institute, Yongin, Gyeonggi-do, Korea.
  • Her JH; Cell Therapy Team, MOGAM Biotechnology Institute, Yongin, Gyeonggi-do, Korea.
  • Cho SY; Cell Therapy Team, MOGAM Biotechnology Institute, Yongin, Gyeonggi-do, Korea.
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lee SH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Hwang YK; Cell Therapy Team, MOGAM Biotechnology Institute, Yongin, Gyeonggi-do, Korea. gabriel9@snu.ac.kr ykhwang@mogam.re.kr.
  • Heo DS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Cancer Immunol Res ; 4(3): 215-24, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26787822
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Imunoterapia Adotiva / Linfoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Imunoterapia Adotiva / Linfoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article